This page contains exclusive content for the member of the following sections: TTS, IHCTAS. Log in to view.
Presenter: Rolf N., Barth, Baltimore, MD, USA
Authors: Rolf N. Barth
Rolf N. Barth, University of Maryland, Baltimore, MD, USA.
We have established a non-human primate (NHP) model of facial vascularized composite allografts (VCA) to study the unique immunobiology of grafts containing multiple tissues types. Standard and experimental immunosuppressive therapies were investigated to determine the immunosuppressive requirements of VCA. Data regarding the use of concomitant vascularized bone marrow as a component of an immunosuppressive strategy that prolonged rejection-free graft survival will be presented. The complications and patterns of rejection uniquely associated with VCA will be presented with reference to the predictive value of the non-human primate as a preclinical model.
By viewing the material on this site you understand and accept that:
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada